Mar 31, 2017

United Therapeutics Q1 2017 Earnings Report

Total Revenue
$371M
Previous year: $369M
+0.4%
EPS
$3.61
Previous year: $3.02
+19.5%
Gross Profit
$356M
Previous year: $368M
-3.3%
Cash and Equivalents
$1.12B
Previous year: $847M
+32.6%
Free Cash Flow
$215M
Total Assets
$2.56B
Previous year: $2.19B
+16.8%

United Therapeutics

United Therapeutics